Q-Line Biotech IPO
GMP, Subscription, Price, Dates & Financial Details
Medical Equipment
Open Date
Thu, 21 May 2026
Close Date
Mon, 25 May 2026
Price Band
₹ 326 – 343
Lot Size
400
Issue Size
₹ 214.00 Cr
Minimum Investment
₹ 274,400 (800 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Q-Line Biotech IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹214.00 Crore, comprising a fresh issue of 62.53 Lakh equity shares aggregating to ₹214.00 Crore.
The Q-Line Biotech IPO remained open for subscription from May 21, 2026, to May 25, 2026. The basis of allotment was finalized on May 26, 2026, and the company's shares were listed on NSE SME Platform on May 29, 2026.
The company had fixed the price band at ₹326 to ₹343 per share, with a lot size of 400 shares. Retail investors were required to make a minimum investment of ₹274,400 (based on the upper price band) to apply for one lot.
Purva Sharegistry India Pvt Ltd served as the registrar to the issue. Hem Securities Limited, and Share India Capital Services Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Q-Line Biotech Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Q-Line Biotech IPO Timeline (Tentative)
- IPO Open Date
- Thu, 21 May 26
- IPO Close Date
- Mon, 25 May 26
- Basis of Allotment
- Tue, 26 May 26
- Initiation of Refunds
- Wed, 27 May 26
- Credit of Shares to Demat
- Wed, 27 May 26
- Listing Date
- Fri, 29 May 26 — NSE & BSE
Open Date
21 May 2026
Close Date
25 May 2026
Basis Of Allotment
26 May 2026
Listing Date
29 May 2026
IPO Subscription
Check Live Subscription →The Q-Line Biotech IPO has received bids for 42,62,45,600 shares against 41,58,800 shares offered, resulting in an overall subscription of 102.49x. the NII category is subscribed 146.33x, Retail Investors 71.44x, and QIBs 123.94x. Within the NII category, BNII is subscribed 178.82x, while SNII is subscribed 81.35x.
QIB
123.94x
NII
146.33x
BNII
178.82x
SNII
81.35x
RII
71.44x
Total
102.49x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 20,79,200 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 11,88,000 shares (28.57%), while Non-Institutional Investors (NIIs) receive 8,91,600 shares (21.44%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,188,000 | 28.57% |
| Non-Institutional | 891,600 | 21.44% |
| BNII | 594,400 | 14.29% |
| SNII | 297,200 | 7.15% |
| Retail Investors | 2,079,200 | 50% |
| Total | 4,158,800 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 561.34 | 455.49 | 339.25 | 251.58 |
| Revenue | 236.5 | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 38.69 | 28.13 | 34.44 | 32.1 |
| Net Worth | -0.04 | 189.95 | 161.81 | 127.37 |
| Reserve & Surplus | 21288920 | 188.37 | 160.24 | 125.79 |
| Total Borrowings | 243.85 | 164.95 | 96.91 | 73.65 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Q-Line Biotech Limited KPI Information
| Particular | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 16.88 | 17.66 | 19.25 | 22.14 |
| ROCE % | 13.32 | 23.74 | 21.29 | 25.2 |
| Debt / Equity | 1.06 | 0.87 | 0.6 | 0.58 |
| RoNW % | 16.88 | 23.74 | 21.29 | 25.2 |
| Pat Margin % | 16.65 | 8.97 | 16.92 | 17.56 |
Peers Comparison
No Peer Comparision Available
About Q-Line Biotech Limited
Q-Line Biotech IPO Promoters
- Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty
- Abhay Agrawal
Promoters Holding
Holding Pre Issue
96.77%
Holding Post Issue
67.51%
Q-Line Biotech IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- To meet Working Capital requirements
- Repayment of certain borrowing availed by our Company, in part or full
- General Corporate Purpose
Q-Line Biotech Limited Address / Contact Details
Q-Line Biotech Limited
298-281, Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Email:compliance@qlinebiotech.com
Telephone: +91 522-2435570
Website:https://qlinebiotech.com/
IPO Snapshot
Q-Line Biotech IPO Lot Size
The Q-Line Biotech IPO has a lot size of 400 shares. Retail investors require a minimum investment of ₹2,74,400 by applying for 2 lot (800 shares). The maximum application allowed for the retail category is 2 lots (800 shares), requiring an investment of ₹2,74,400.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 800 | 274,400.00 |
| Retail (Max) | 2 | 800 | 274,400.00 |
| S-HNI (Min) | 3 | 1,200 | 411,600.00 |
| S-HNI (Max) | 7 | 2,800 | 960,400.00 |
| B-HNI (Min) | 8 | 3,200 | 1,097,600.00 |
Issue Reservation
- QIB — 28.57%
- NII — 21.44%
- RII — 50%
Book Running Lead Managers
- Hem Securities Limited
- Share India Capital Services Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Q-Line Biotech IPO?
Q-Line Biotech IPO is a Book-building IPO with a total issue size of ₹214 crore. The Q-Line Biotech IPO price band is ₹326 to 343 per share. The Q-Line Biotech IPO subscription opens on Thu, May 21, 2026, and closes on Mon, May 25, 2026. The Q-Line Biotech IPO will be listed on the NSE. Purva Sharegistry India Pvt Ltd is the registrar for the Q-Line Biotech IPO.
When will the Q-Line Biotech IPO open for subscription?
The Q-Line Biotech IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026
What is Q-Line Biotech IPO Price Band?
Q-Line Biotech IPO Price Band is ₹326 to 343 per share.
What is Q-Line Biotech IPO Lot Size?
Q-Line Biotech IPO lot size is 400 shares, Retail investors need a minimum investment of ₹274400 based on the upper price band
What is the minimum investment for Q-Line Biotech IPO?
The minimum investment for Q-Line Biotech IPO is ₹274400, based on one lot of 400 shares at the upper price band of ₹343 per share.
How to apply for Q-Line Biotech IPO?
Investors can apply for the Q-Line Biotech IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, May 25, 2026. The application amount remains blocked until the Q-Line Biotech IPO allotment is finalized.
What is Q-Line Biotech IPO Issue Size?
Q-Line Biotech IPO issue size is ₹214 crores.
What is the Q-Line Biotech IPO Allotment Date?
Q-Line Biotech IPO allotment date is Tue, May 26, 2026.
Who is the Q-Line Biotech IPO Registrar?
The registrar for Q-Line Biotech IPO is Purva Sharegistry India Pvt Ltd. Investors can go to Purva Sharegistry India Pvt Ltd website to check Q-Line Biotech IPO allotment status, refund processing, and other IPO-related information.
What is the Q-Line Biotech IPO GMP?
The Q-Line Biotech IPO GMP (Grey Market Premium) is ₹112 as of Fri, May 29, 2026. Based on the upper price band of ₹343 per share, the estimated Q-Line Biotech IPO listing price is ₹455, indicating a potential listing gain of approximately 32.65% over the issue price.
Who is the Q-Line Biotech IPO Lead Manager?
The book-running lead managers (BRLMs) for the Q-Line Biotech IPO are Hem Securities Limited, and Share India Capital Services Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Q-Line Biotech IPO Red Herring Prospectus (RHP).